Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ionotropic glutamate receptors (iGluRs) are a family of ligand-gated ion channels that mediate fast excitatory synaptic transmission in the central nervous system. The three main subtypes are AMPA, kainate, and NMDA receptors. They are critical for neuronal communication, synaptic plasticity, learning, and memory. Dysfunction of these receptors is implicated in various neurological and psychiatric disorders. Each receptor has a unique subunit composition, ion permeability, and pharmacological profile. Activation leads to influx of cations and membrane depolarization. NMDA receptors are unique due to their voltage-dependent Mg2+ block and requirement for co-agonist binding.
Ligand binding to the receptor opens the ion channel, allowing influx of cations (Na+, K+, Ca2+), leading to membrane depolarization and excitatory postsynaptic currents (EPSCs). NMDA receptors also require co-agonist binding (glycine/D-serine) and are voltage-dependent due to Mg2+ block.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ionotropic Glutamate Receptors (AMPA, Kainate, NMDA) (iGluRs).